Pertussis-induced lung pathology involves excessive inflammation and tissue damage, making α1AT an attractive therapeutic agent due to its antiinflammatory and tissue-protective properties in addition to its anti-PT effects. This evidence concerns the gene SERPINA1 and pertussis.